Figure 4From: Everolimus in metastatic renal cell carcinoma after failure of initial anti–VEGF therapy: final results of a noninterventional studyTime to worsening of Karnofsky performance status by ≥10% by best overall response (safety population). Remission, n = 29; stable disease, n = 124; disease progression, n = 68.Back to article page